
Exosome Diagnostics
Commercializing minimally invasive molecular diagnostics in blood and urine to enable doctors to select optimal therapies for cancer and other diseases.
Employees
Enterprise value
$120—180m
Authorizing premium user...
Commercializing minimally invasive molecular diagnostics in blood and urine to enable doctors to select optimal therapies for cancer and other diseases.